Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic.

Publication ,  Journal Article
Kaufman, HW; Chen, Z; Niles, JK; Fesko, YA
Published in: Jco Clinical Cancer Informatics
October 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Jco Clinical Cancer Informatics

DOI

EISSN

2473-4276

ISSN

2473-4276

Publication Date

October 2022

Volume

6

Start / End Page

e2200102

Related Subject Headings

  • United States
  • Pandemics
  • Neoplasms
  • Humans
  • COVID-19
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kaufman, H. W., Chen, Z., Niles, J. K., & Fesko, Y. A. (2022). New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic. Jco Clinical Cancer Informatics, 6, e2200102. https://doi.org/10.1200/cci.22.00102
Kaufman, Harvey W., Zhen Chen, Justin K. Niles, and Yuri A. Fesko. “New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic.Jco Clinical Cancer Informatics 6 (October 2022): e2200102. https://doi.org/10.1200/cci.22.00102.
Kaufman HW, Chen Z, Niles JK, Fesko YA. New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic. Jco Clinical Cancer Informatics. 2022 Oct;6:e2200102.
Kaufman, Harvey W., et al. “New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic.Jco Clinical Cancer Informatics, vol. 6, Oct. 2022, p. e2200102. Epmc, doi:10.1200/cci.22.00102.
Kaufman HW, Chen Z, Niles JK, Fesko YA. New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic. Jco Clinical Cancer Informatics. 2022 Oct;6:e2200102.

Published In

Jco Clinical Cancer Informatics

DOI

EISSN

2473-4276

ISSN

2473-4276

Publication Date

October 2022

Volume

6

Start / End Page

e2200102

Related Subject Headings

  • United States
  • Pandemics
  • Neoplasms
  • Humans
  • COVID-19